@FierceBiotech: ICYMI yesterday: Gene therapy upstart Audentes bags a new program in buyout. Article | Follow @FierceBiotech
@JohnCFierce: From the early hours file: AstraZeneca backs $80M round for ADC's antibody warhead tech. News | Follow @JohnCFierce
@DamianFierce: ICYMI yesterday: AstraZeneca auctions off troubled psoriasis drug to Valeant in $445M deal. More | Follow @DamianFierce
> Chinese biotech Ascletis raised $35 million in equity financing, cash it plans to put toward its efforts to develop hepatitis C treatments for the Asian market. News
> Baxalta ($BXLT) is pairing up with Switzerland's Novimmune to develop bispecific antibodies for an undisclosed disease target. Release
> Florida's Sancilio Pharmaceuticals filed for an $86 million IPO, looking to raise cash for its lipid-based candidates in sickle cell disease, short bowel syndrome, high triglycerides and non-alcoholic fatty liver disease (NAFLD). More
> Gilead Sciences' ($GILD) two-drug HIV combo F/TAF met its primary goal of measuring up to Truvada in a Phase III trial. Item
Medical Device News
@FierceMedDev: Agena Bioscience opening office in China, aims to sell spectrometry systems in the country. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Quanterix and Banyan Biomarkers forge ahead with brain injury diagnostic tech. More | Follow @VarunSaxena2
@EmilyWFierce: DynoSense selects Chinese marketing partner for handheld monitoring device. Story | Follow @EmilyWFierce
> HeartWare looks to diversify into mitral valve repair with $929M purchase of Valtech Cardio. Story
> FDA partners with nonprofit device incubator Fogarty Institute to improve approval efficiency. More
Pharma News
@FiercePharma: India's Maharashtra state asks blood banks to send plasma to Reliance Life Sciences in albumin shortage. FiercePharmaAsia story | Follow @FiercePharma
@CarlyHFierce: ICYMI: Jardiance and its CV data? They're no knockout punch for stalwart Januvia, Merck says. Report | Follow @CarlyHFierce
> Valeant doubles size of its HQ as deal spree continues. More
> European pharma lobby says 'non' to French funding for off-label Avastin. Article
Biotech Research News
> TGen IDs targets for nonalcoholic fatty liver disease. Item
> Ziopharm tests new approach to engineering CAR-Ts for solid tumors. Report
> Eta-amyloid discovered in Alzheimer's adds new piece to the complex puzzle. More
> New research highlights role of SKA2 gene in PTSD, suicide. Article
> Gene variant linked to a 10-year delay in Alzheimer's onset. Story
Diagnostics News
> FDA scolds Cepheid for manufacturing issues in Sweden. More
> Exact Sciences wins CMS panel vote for Cologuard pricing. Report
> JAMA: Two genetic tests, not one, could work better at diagnosing autism. More
> Agena Bioscience opening office in China, aims to sell spectrometry systems in the country. Story
> FDA scolds Cepheid for manufacturing issues in Sweden. Article
Pharma Marketing News
> Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use. Item
> Pharma TV ads are good for the business bottom line, study says. Report
> New Pradaxa antidote study preps Boehringer for market-share turnaround: ESC. Story
> AstraZeneca sales team revving up for new Brilinta marketing push. More
> Valeant bets the odds on AZ's psoriasis med in $100M-plus development deal. Article